Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Number Of Opioid Addiction Cases

How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market?
The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance development where larger quantities of the substance are required for the same effects, potentially triggering opioid use disorder. For instance, data from the Centers for Disease Control and Prevention, a health organization based in the US, showed that overdoses from synthetic opioid drugs elevated by 4.1%, moving from 21.8 to 22.7 between 2021 and 2022. Therefore, the escalating instances of opioid dependency are contributing to the expansion of the opioid use disorder (OUD) market.

Get Your Opioid Use Disorder (OUD) Market Report Here:
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

What growth opportunities are expected to drive the opioid use disorder (oud) market's CAGR through 2034?
The market size for opioid use disorder (OUD) has seen significant expansion lately. The market indicates a growth from $3.96 billion in 2024 to $4.39 billion in 2025, exhibiting a 10.9% compound annual growth rate (CAGR). The historical growth can be credited to elements such as accelerated prescription rates, advancements in pain management, enhanced drug marketing strategies, and stigmatization of addiction.

Experts predict substantial expansion in the market for opioid use disorder (OUD) in the coming years. The market is projected to reach $6.94 billion by 2029, with a compound annual growth rate (CAGR) of 12.1%. Factors contributing to this growth in the projected period include regulatory actions, emphasis on other methods of managing pain, improvement in treatment accessibility, and public health endeavors. The forthcoming period is expected to witness trends such as tech advancements in treatment, personalized treatment methods, combined healthcare models, support programs based in communities, along with prior intervention and prevention.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What are the emerging trends shaping the future of the opioid use disorder (oud) market?
One noticeable trend catching on in the opioid use disorder (OUD) market is product innovation. Top-notch firms in the OUD market are focusing on the creation of novelty products to maintain their market standing. To illustrate, the U.S. Food and Drug Administration, an American federal institution, gave its approval to Brixadi (buprenorphine) extended-release injection in May 2023 for treating moderate to severe OUD. Brixadi has two available dosage forms - a weekly injection suitable for patients who have initiated treatment with a one-time dose of a transmucosal buprenorphine product or who are currently under medication, and a monthly variant for individuals already under medication.

Which growth-oriented segments of the opioid use disorder (oud) market are leading the industry's development?
The opioid use disorder (OUD) market covered in this report is segmented -

1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:
1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets, Vivitrol
3) By Methadone: Methadone Tablets, Methadone Oral Solution

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

What regions are leading the charge in the opioid use disorder (oud) market?
North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What companies are at the forefront of innovation in the opioid use disorder (oud) market?
Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Is Covered In The Opioid Use Disorder (OUD) Global Market Report?

• Market Size Forecast: Examine the opioid use disorder (oud) market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the opioid use disorder (oud) market for a structured understanding.
• Key Players Overview: Analyze major players in the opioid use disorder (oud) market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the opioid use disorder (oud) market.
• Segment Contributions: Evaluate how different segments drive overall growth in the opioid use disorder (oud) market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the opioid use disorder (oud) market.
• Industry Challenges: Identify potential risks and obstacles affecting the opioid use disorder (oud) market.
• Competitive Landscape: Review strategic developments in the opioid use disorder (oud) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.